Phase
Condition
Vascular Diseases
Diabetes Prevention
Diabetes And Hypertension
Treatment
MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 6 Weeks
Comparator: atorvastatin / Duration of Treatment: 6 Weeks
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Greater than 18 years of age
Treated for at least the last 3 months with a daily dose of atorvastatin 40 mg
Existing coronary heart disease and cholesterol > 4.0 mmol/l
Exclusion
Exclusion Criteria:
Uncontrolled diabetes
Elevated liver function tests
Elevated creatine kinase (ck)
Triglycerides (tg) > 4.5 mmol/l
Drug or alcohol dependency within 6 months prior to visit 1
Woman receiving hormonal therapy who have not been maintained on a stable dose andregimen for at least 8 weeks and are willing to continue the same regimen for theduration of the study
Woman of childbearing potential not using an acceptable method of birth control
Women who are pregnant or breast feeding